1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Leukemia Therapeutic Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Induction Therapy
1.2.3 Consolidation Therapy
1.2.4 Maintenance Therapy
1.3 Market by Application
1.3.1 Global Leukemia Therapeutic Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Cancer Research Centers
1.3.3 Diagnostic Laboratories
1.3.4 Hospitals andClinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Leukemia Therapeutic Market Perspective (2018-2029)
2.2 Leukemia Therapeutic Growth Trends by Region
2.2.1 Global Leukemia Therapeutic Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Leukemia Therapeutic Historic Market Size by Region (2018-2023)
2.2.3 Leukemia Therapeutic Forecasted Market Size by Region (2024-2029)
2.3 Leukemia Therapeutic Market Dynamics
2.3.1 Leukemia Therapeutic Industry Trends
2.3.2 Leukemia Therapeutic Market Drivers
2.3.3 Leukemia Therapeutic Market Challenges
2.3.4 Leukemia Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Leukemia Therapeutic Players by Revenue
3.1.1 Global Top Leukemia Therapeutic Players by Revenue (2018-2023)
3.1.2 Global Leukemia Therapeutic Revenue Market Share by Players (2018-2023)
3.2 Global Leukemia Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Leukemia Therapeutic Revenue
3.4 Global Leukemia Therapeutic Market Concentration Ratio
3.4.1 Global Leukemia Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Leukemia Therapeutic Revenue in 2022
3.5 Leukemia Therapeutic Key Players Head office and Area Served
3.6 Key Players Leukemia Therapeutic Product Solution and Service
3.7 Date of Enter into Leukemia Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Leukemia Therapeutic Breakdown Data by Type
4.1 Global Leukemia Therapeutic Historic Market Size by Type (2018-2023)
4.2 Global Leukemia Therapeutic Forecasted Market Size by Type (2024-2029)
5 Leukemia Therapeutic Breakdown Data by Application
5.1 Global Leukemia Therapeutic Historic Market Size by Application (2018-2023)
5.2 Global Leukemia Therapeutic Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Leukemia Therapeutic Market Size (2018-2029)
6.2 North America Leukemia Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Leukemia Therapeutic Market Size by Country (2018-2023)
6.4 North America Leukemia Therapeutic Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Leukemia Therapeutic Market Size (2018-2029)
7.2 Europe Leukemia Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Leukemia Therapeutic Market Size by Country (2018-2023)
7.4 Europe Leukemia Therapeutic Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Leukemia Therapeutic Market Size (2018-2029)
8.2 Asia-Pacific Leukemia Therapeutic Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Leukemia Therapeutic Market Size by Region (2018-2023)
8.4 Asia-Pacific Leukemia Therapeutic Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Leukemia Therapeutic Market Size (2018-2029)
9.2 Latin America Leukemia Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Leukemia Therapeutic Market Size by Country (2018-2023)
9.4 Latin America Leukemia Therapeutic Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Leukemia Therapeutic Market Size (2018-2029)
10.2 Middle East & Africa Leukemia Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Leukemia Therapeutic Market Size by Country (2018-2023)
10.4 Middle East & Africa Leukemia Therapeutic Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Genzyme
11.1.1 Genzyme Company Detail
11.1.2 Genzyme Business Overview
11.1.3 Genzyme Leukemia Therapeutic Introduction
11.1.4 Genzyme Revenue in Leukemia Therapeutic Business (2018-2023)
11.1.5 Genzyme Recent Development
11.2 Novartis International
11.2.1 Novartis International Company Detail
11.2.2 Novartis International Business Overview
11.2.3 Novartis International Leukemia Therapeutic Introduction
11.2.4 Novartis International Revenue in Leukemia Therapeutic Business (2018-2023)
11.2.5 Novartis International Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Leukemia Therapeutic Introduction
11.3.4 Pfizer Revenue in Leukemia Therapeutic Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 Roche Holding
11.4.1 Roche Holding Company Detail
11.4.2 Roche Holding Business Overview
11.4.3 Roche Holding Leukemia Therapeutic Introduction
11.4.4 Roche Holding Revenue in Leukemia Therapeutic Business (2018-2023)
11.4.5 Roche Holding Recent Development
11.5 Celgene Corporation
11.5.1 Celgene Corporation Company Detail
11.5.2 Celgene Corporation Business Overview
11.5.3 Celgene Corporation Leukemia Therapeutic Introduction
11.5.4 Celgene Corporation Revenue in Leukemia Therapeutic Business (2018-2023)
11.5.5 Celgene Corporation Recent Development
11.6 Ariad Pharmaceuticals
11.6.1 Ariad Pharmaceuticals Company Detail
11.6.2 Ariad Pharmaceuticals Business Overview
11.6.3 Ariad Pharmaceuticals Leukemia Therapeutic Introduction
11.6.4 Ariad Pharmaceuticals Revenue in Leukemia Therapeutic Business (2018-2023)
11.6.5 Ariad Pharmaceuticals Recent Development
11.7 Clavis Pharma
11.7.1 Clavis Pharma Company Detail
11.7.2 Clavis Pharma Business Overview
11.7.3 Clavis Pharma Leukemia Therapeutic Introduction
11.7.4 Clavis Pharma Revenue in Leukemia Therapeutic Business (2018-2023)
11.7.5 Clavis Pharma Recent Development
11.8 Sunesis Pharmaceuticals
11.8.1 Sunesis Pharmaceuticals Company Detail
11.8.2 Sunesis Pharmaceuticals Business Overview
11.8.3 Sunesis Pharmaceuticals Leukemia Therapeutic Introduction
11.8.4 Sunesis Pharmaceuticals Revenue in Leukemia Therapeutic Business (2018-2023)
11.8.5 Sunesis Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Leukemia Therapeutic Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Induction Therapy
Table 3. Key Players of Consolidation Therapy
Table 4. Key Players of Maintenance Therapy
Table 5. Global Leukemia Therapeutic Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Leukemia Therapeutic Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Leukemia Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Leukemia Therapeutic Market Share by Region (2018-2023)
Table 9. Global Leukemia Therapeutic Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Leukemia Therapeutic Market Share by Region (2024-2029)
Table 11. Leukemia Therapeutic Market Trends
Table 12. Leukemia Therapeutic Market Drivers
Table 13. Leukemia Therapeutic Market Challenges
Table 14. Leukemia Therapeutic Market Restraints
Table 15. Global Leukemia Therapeutic Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Leukemia Therapeutic Market Share by Players (2018-2023)
Table 17. Global Top Leukemia Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leukemia Therapeutic as of 2022)
Table 18. Ranking of Global Top Leukemia Therapeutic Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Leukemia Therapeutic Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Leukemia Therapeutic Product Solution and Service
Table 22. Date of Enter into Leukemia Therapeutic Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Leukemia Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Leukemia Therapeutic Revenue Market Share by Type (2018-2023)
Table 26. Global Leukemia Therapeutic Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Leukemia Therapeutic Revenue Market Share by Type (2024-2029)
Table 28. Global Leukemia Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Leukemia Therapeutic Revenue Market Share by Application (2018-2023)
Table 30. Global Leukemia Therapeutic Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Leukemia Therapeutic Revenue Market Share by Application (2024-2029)
Table 32. North America Leukemia Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Leukemia Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Leukemia Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Leukemia Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Leukemia Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Leukemia Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Leukemia Therapeutic Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Leukemia Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Leukemia Therapeutic Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Leukemia Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Leukemia Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Leukemia Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Leukemia Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Leukemia Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Leukemia Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 47. Genzyme Company Detail
Table 48. Genzyme Business Overview
Table 49. Genzyme Leukemia Therapeutic Product
Table 50. Genzyme Revenue in Leukemia Therapeutic Business (2018-2023) & (US$ Million)
Table 51. Genzyme Recent Development
Table 52. Novartis International Company Detail
Table 53. Novartis International Business Overview
Table 54. Novartis International Leukemia Therapeutic Product
Table 55. Novartis International Revenue in Leukemia Therapeutic Business (2018-2023) & (US$ Million)
Table 56. Novartis International Recent Development
Table 57. Pfizer Company Detail
Table 58. Pfizer Business Overview
Table 59. Pfizer Leukemia Therapeutic Product
Table 60. Pfizer Revenue in Leukemia Therapeutic Business (2018-2023) & (US$ Million)
Table 61. Pfizer Recent Development
Table 62. Roche Holding Company Detail
Table 63. Roche Holding Business Overview
Table 64. Roche Holding Leukemia Therapeutic Product
Table 65. Roche Holding Revenue in Leukemia Therapeutic Business (2018-2023) & (US$ Million)
Table 66. Roche Holding Recent Development
Table 67. Celgene Corporation Company Detail
Table 68. Celgene Corporation Business Overview
Table 69. Celgene Corporation Leukemia Therapeutic Product
Table 70. Celgene Corporation Revenue in Leukemia Therapeutic Business (2018-2023) & (US$ Million)
Table 71. Celgene Corporation Recent Development
Table 72. Ariad Pharmaceuticals Company Detail
Table 73. Ariad Pharmaceuticals Business Overview
Table 74. Ariad Pharmaceuticals Leukemia Therapeutic Product
Table 75. Ariad Pharmaceuticals Revenue in Leukemia Therapeutic Business (2018-2023) & (US$ Million)
Table 76. Ariad Pharmaceuticals Recent Development
Table 77. Clavis Pharma Company Detail
Table 78. Clavis Pharma Business Overview
Table 79. Clavis Pharma Leukemia Therapeutic Product
Table 80. Clavis Pharma Revenue in Leukemia Therapeutic Business (2018-2023) & (US$ Million)
Table 81. Clavis Pharma Recent Development
Table 82. Sunesis Pharmaceuticals Company Detail
Table 83. Sunesis Pharmaceuticals Business Overview
Table 84. Sunesis Pharmaceuticals Leukemia Therapeutic Product
Table 85. Sunesis Pharmaceuticals Revenue in Leukemia Therapeutic Business (2018-2023) & (US$ Million)
Table 86. Sunesis Pharmaceuticals Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Leukemia Therapeutic Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Leukemia Therapeutic Market Share by Type: 2022 VS 2029
Figure 3. Induction Therapy Features
Figure 4. Consolidation Therapy Features
Figure 5. Maintenance Therapy Features
Figure 6. Global Leukemia Therapeutic Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Leukemia Therapeutic Market Share by Application: 2022 VS 2029
Figure 8. Cancer Research Centers Case Studies
Figure 9. Diagnostic Laboratories Case Studies
Figure 10. Hospitals andClinics Case Studies
Figure 11. Others Case Studies
Figure 12. Leukemia Therapeutic Report Years Considered
Figure 13. Global Leukemia Therapeutic Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Leukemia Therapeutic Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Leukemia Therapeutic Market Share by Region: 2022 VS 2029
Figure 16. Global Leukemia Therapeutic Market Share by Players in 2022
Figure 17. Global Top Leukemia Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leukemia Therapeutic as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Leukemia Therapeutic Revenue in 2022
Figure 19. North America Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Leukemia Therapeutic Market Share by Country (2018-2029)
Figure 21. United States Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Leukemia Therapeutic Market Share by Country (2018-2029)
Figure 25. Germany Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Leukemia Therapeutic Market Share by Region (2018-2029)
Figure 33. China Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Leukemia Therapeutic Market Share by Country (2018-2029)
Figure 41. Mexico Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Leukemia Therapeutic Market Share by Country (2018-2029)
Figure 45. Turkey Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Leukemia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Genzyme Revenue Growth Rate in Leukemia Therapeutic Business (2018-2023)
Figure 48. Novartis International Revenue Growth Rate in Leukemia Therapeutic Business (2018-2023)
Figure 49. Pfizer Revenue Growth Rate in Leukemia Therapeutic Business (2018-2023)
Figure 50. Roche Holding Revenue Growth Rate in Leukemia Therapeutic Business (2018-2023)
Figure 51. Celgene Corporation Revenue Growth Rate in Leukemia Therapeutic Business (2018-2023)
Figure 52. Ariad Pharmaceuticals Revenue Growth Rate in Leukemia Therapeutic Business (2018-2023)
Figure 53. Clavis Pharma Revenue Growth Rate in Leukemia Therapeutic Business (2018-2023)
Figure 54. Sunesis Pharmaceuticals Revenue Growth Rate in Leukemia Therapeutic Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Genzyme Novartis International Pfizer Roche Holding Celgene Corporation Ariad Pharmaceuticals Clavis Pharma Sunesis Pharmaceuticals